AI-driven platform that identifies and optimizes small molecules targeting RNA to accelerate novel drug discovery.
Serna Bio uses AI to identify and optimize small molecules that interact with RNA targets, enabling drug discovery for diseases difficult to treat with traditional modalities. The company focuses on RNA-targeted therapeutics by combining AI-powered workflows with small molecule chemistry. Their approach aims to unlock disease biology intractable to protein-targeting drugs. Serna Bio is a product of Serna Bio.